Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes

The Emerging Role of Heme Oxygenase and Its Metabolites in the Regulation of Cardiovascular Function

(2012) David E. Stec et al.   International Journal of Hypertension

The role of carbon monoxide in metabolic disease

(2011) Yeonsoo Joe et al.   Annals of the New York Academy of Sciences

Inhibition of Nitric Oxide–Stimulated Vasorelaxation by Carbon Monoxide-Releasing Molecules

(2011) Antonia Marazioti et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential

(2011) Kim H. Chan et al.   CLINICAL SCIENCE

Exhaled Carbon Monoxide and Risk of Metabolic Syndrome and Cardiovascular Disease in the Community

(2010) Susan Cheng et al.   CIRCULATION

Endogenous carbon monoxide production in disease

(2010) Elizabeth Oesterling Owens   CLINICAL BIOCHEMISTRY

Heme oxygenase-1 and carbon monoxide promote neovascularization after myocardial infarction by modulating the expression of HIF-1α, SDF-1α and VEGF-B

(2010) Päivi Lakkisto et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Heme Oxygenase 1 Determines Atherosclerotic Lesion Progression Into a Vulnerable Plaque

(2009) Caroline Cheng et al.   CIRCULATION

After vascular injury, heme oxygenase-1/carbon monoxide enhances re-endothelialization via promoting mobilization of circulating endothelial progenitor cells

(2009) H.-H. LIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Treatment of Obese Diabetic Mice With a Heme Oxygenase Inducer Reduces Visceral and Subcutaneous Adiposity, Increases Adiponectin Levels, and Improves Insulin Sensitivity and Glucose Tolerance

(2008) M. Li et al.   DIABETES